dr. mei on investigational car t-cell therapies and antibody-drug conjugates in hodgkin lymphoma
Published 5 years ago • 156 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
2:29
dr maakaron on choosing between bispecific antibodies and car t-cell therapy in dlbcl
-
9:05
understanding car t-cell therapy for lymphoma with andrew zelenetz, md, phd
-
16:32
new antibodies and antibody-drug conjugates for b-cell lymphoma
-
36:37
car t-cell therapy in non-hodgkin lymphoma and multiple myeloma: a clinical update
-
44:46
immunotherapy beyond car t-cell therapy
-
26:45
chronic fatigue syndrome: key symptoms | diagnosis with dr. olivia lesslar
-
33:15
hodgkin lymphoma: how treatment may change in 2023 | what you should be asking your doctor
-
5:53
patient discusses his car t-cell therapy on house of wellness
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
1:10:38
car t-cell therapy in high-risk non-hodgkin lymphoma
-
6:24
introduction: antibody-drug conjugates in lymphoma
-
0:40
antibody-drug conjugates and checkpoint inhibitors in hodgkin lymphoma
-
10:43
immunotherapy and lymphoma treatment
-
1:01:59
update on car t-cell therapy | lrf webinars
-
0:36
how successful is car-t for b-cell lymphoma?
-
1:24
dr. flinn on car t-cell therapy in non-hodgkin lymphoma
-
1:41
dr. andreadis on the current state of car t-cell therapy in lymphoma
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
2:01
dr. wong on an investigational antibody-drug conjugate in multiple myeloma
-
1:58
dr. wang on car t-cell therapy resistance in mcl
-
1:44
dr. cheson on antibody drug conjugates in lymphomas
-
57:44
understanding car t cell therapy for the treatment of lymphoma